Jack Ragheb

Jack Ragheb currently serves as the Senior Vice President of Translational Science. He graduated from Johns Hopkins University and School of Medicine and is a diplomate of the American Board of Allergy and Immunology. Ragheb’s career includes significant roles such as Senior Medical Fellow for Immunology at Eli Lilly & Co., Chief Medical Research Officer in the Laboratory of Immunology at the Office of Biotechnology Products, CDER, U.S. Food Drug Administration, and Attending Physician on the Allergy-Immunology Service at NIAID. He also worked as a Senior Clinical Investigator in the Laboratory of Immunology at the National Eye Institute, part of the National Institutes of Health. His research and publications cover a broad range of topics including retrovirology, gene therapy, immune activation, therapeutic protein immunogenicity, and clinical trials in immune tolerance. Additionally, Ragheb is the Scientific Founder of JoMoCo Inc., contributing to advancements in the field of immunology.